Past major depression and smoking cessation outcome: a systematic review and meta-analysis update - PubMed (original) (raw)
Review
Past major depression and smoking cessation outcome: a systematic review and meta-analysis update
Brian Hitsman et al. Addiction. 2013 Feb.
Abstract
Aims: To update our prior meta-analysis that showed past major depression (MD+) to be unrelated to smoking cessation outcome.
Methods: Eligible trials included 14 from our original review and 28 identified through an updated systematic review (2000-2009). We coded for assessment of past MD, exclusion for recent MD episode (MDE; ≤6 months versus no exclusion), duration/modality of cognitive behavioral treatment (CBT; face-to-face versus self-help) and other factors. To minimize influence of experimental treatments that may selectively benefit MD+ smokers we analyzed placebo/lowest intensity control arms only. Study-specific ORs for the effect of past MD on short-term (≤3 months) and long-term (≥6 months) abstinence were estimated and combined using random effects. Two-way interaction models of past MD with study methodology and treatment factors were used to evaluate hypothesized moderators of the past MD-abstinence association.
Results: MD+ smokers had 17% lower odds of short-term abstinence (n = 35, OR = 0.83, 95% CI = 0.72-0.95, P = 0.009) and 19% lower odds of long-term abstinence (n = 38, OR = 0.81, 95% CI = 0.67-0.97, P = 0.023) than MD- smokers after excluding the sole study of varenicline because of its antidepressant properties. The association between past MD and abstinence was affected by methodological (recent MDE exclusion, type of MD assessment) and treatment (CBT modality) factors.
Conclusions: Past major depression has a modest adverse effect on abstinence during and after smoking cessation treatment. An increased focus on the identification of effective treatments or treatment adaptations that eliminate this disparity in smoking cessation for MD+ smokers is needed.
© 2012 The Authors, Addiction © 2012 Society for the Study of Addiction.
Figures
Figure 1
Flow diagram summarizing the study selection process.
Figure 2
A forest plot of the odds ratios (OR) comparing short-term abstinence rates for past MD+ versus MD− smokers in the placebo/lowest intensity control arms. The size of the circle for each individual effect is proportional to the study’s weight in the analysis. Area inversely proportional to the variance of the log-odds ratio estimator. Error bars show the 95% confidence interval. The diamond indicates the overall short-term random effect. The point of no association is indicated by the solid vertical line. An OR less than 1 indicates a lower abstinence rate among past MD+ smokers.
Figure 3
A forest plot of the odds ratios (OR) comparing long-term abstinence rates for past MD+ versus MD− smokers in the placebo/lowest intensity control arms. The size of the circle for each individual effect is proportional to the study’s weight in the analysis. Area inversely proportional to the variance of the log-odds ratio estimator. Error bars show the 95% confidence interval. The diamond indicates the overall long-term random effect. The point of no association is indicated by the solid vertical line. An OR less than 1 indicates a lower abstinence rate among past MD+ smokers.
Similar articles
- Smoking cessation interventions for smokers with current or past depression.
van der Meer RM, Willemsen MC, Smit F, Cuijpers P. van der Meer RM, et al. Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Cochrane Database Syst Rev. 2013. PMID: 23963776 Review. - Interventions for preventing weight gain after smoking cessation.
Farley AC, Hajek P, Lycett D, Aveyard P. Farley AC, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3. Cochrane Database Syst Rev. 2012. PMID: 22258966 Updated. Review. - Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Swift RM, Leggio L, Monti PM. Rohsenow DJ, et al. Addiction. 2017 Oct;112(10):1808-1820. doi: 10.1111/add.13861. Epub 2017 Jul 4. Addiction. 2017. PMID: 28498504 Clinical Trial. - Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH, Dalili MN, López-López JA, Keeney E, Phillippo D, Munafò MR, Stevenson M, Caldwell DM, Welton NJ. Thomas KH, et al. Health Technol Assess. 2021 Oct;25(59):1-224. doi: 10.3310/hta25590. Health Technol Assess. 2021. PMID: 34668482 - Antidepressants for smoking cessation.
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Hughes JR, et al. Cochrane Database Syst Rev. 2014 Jan 8;2014(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Cochrane Database Syst Rev. 2014. PMID: 24402784 Free PMC article. Updated. Review.
Cited by
- Interventions for tobacco use cessation in people living with HIV.
Mdege ND, Shah S, Dogar O, Pool ER, Weatherburn P, Siddiqi K, Zyambo C, Livingstone-Banks J. Mdege ND, et al. Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3. Cochrane Database Syst Rev. 2024. PMID: 39101506 Review. - Texas tobacco quitline knowledge, attitudes, and practices within healthcare agencies serving individuals with behavioral health needs: A multimethod study.
Britton M, Rogova A, Chen TA, Martinez Leal I, Kyburz B, Williams T, Patel M, Reitzel LR. Britton M, et al. Prev Med Rep. 2023 May 24;35:102256. doi: 10.1016/j.pmedr.2023.102256. eCollection 2023 Oct. Prev Med Rep. 2023. PMID: 37752980 Free PMC article. - Smoking Cessation and Changes in Anxiety and Depression in Adults With and Without Psychiatric Disorders.
Wu AD, Gao M, Aveyard P, Taylor G. Wu AD, et al. JAMA Netw Open. 2023 May 1;6(5):e2316111. doi: 10.1001/jamanetworkopen.2023.16111. JAMA Netw Open. 2023. PMID: 37256615 Free PMC article. Clinical Trial. - Change in cardiovascular health among adults with current or past major depressive disorder enrolled in intensive smoking cessation treatment.
Carroll AJ, Huffman MD, Wileyto EP, Khan SS, Fox E, Smith JD, Bauer AM, Leone FT, Schnoll RA, Hitsman B. Carroll AJ, et al. J Affect Disord. 2023 Jul 15;333:527-534. doi: 10.1016/j.jad.2023.04.089. Epub 2023 Apr 28. J Affect Disord. 2023. PMID: 37119868 Free PMC article. Clinical Trial. - Treatment adherence in a smoking cessation clinical trial for individuals with current or past major depressive disorder: Predictors and association with cessation.
Schnoll R, Barrila GM, Dalsimer S, Hosie Quinn M, Bauer AM, Fox E, Olonoff M, Jao NC, Leone F, Huffman MD, Khan SS, Gollan JK, Papandonatos GD, Hitsman B. Schnoll R, et al. Addict Behav. 2023 Aug;143:107686. doi: 10.1016/j.addbeh.2023.107686. Epub 2023 Mar 5. Addict Behav. 2023. PMID: 36893514 Free PMC article. Clinical Trial.
References
- Wilhelm K, et al. Grey lungs and blue moods: smoking cessation in the context of lifetime depression history. Aust N Z J Psychiatry. 2004;38(11–12):896–905. - PubMed
- Ziedonis D, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10(12):1691–715. - PubMed
- Covey LS, et al. Effect of history of alcoholism or major depression on smoking cessation. Am J Psychiatry. 1993;150(10):1546–7. - PubMed
- Niaura R, et al. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999;1(3):251–7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous